drugset / Trial / NCT00596245
Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets
RandomizedParallel-groupOpen-labelBasic science
Summary
This is an open-label, parallel group, single-center study. The study design consists of a screening and a treatment period. A total of 42 (approximately 21 of each sex) non-smoking healthy volunteers aged 18 - 35.
Timeline
- Start
- 2007-10
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MT400 | Unknown | — | — |
| Subject | Naproxen | Small molecule | 550 mg | — |
Indications
No indication recorded.